Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry

Journal of Proteome Research

Volumn 9, Issue 12, 2010, Pages 6440-6449

  Zeng, Xuemei ^a   Hood, Brian L ^a   Sun, Mai ^a   Conrads, Thomas P ^a,b   Day, Roger S ^a   Weissfeld, Joel L ^a,b   Siegfried, Jill M ^a,b   Bigbee, William L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDASE; GLYCOPEPTIDE; GLYCOPROTEIN; HYDRAZIDE; PLASMA PROTEIN; PROTEOME; RESIN; TRYPSIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EARLY DIAGNOSIS; ELUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEOMICS; SQUAMOUS CELL CARCINOMA; TANDEM MASS SPECTROMETRY;

ADENOCARCINOMA; AGED; AMINO ACID SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, LIQUID; CLUSTER ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPEPTIDES; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 78649861704     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100696n     Document Type: Article

References (37)

1. Okada, M.; Nishio, W.; Sakamoto, T.; Uchino, K.; Yuki, T.; Nakagawa, A.; Tsubota, N. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection J. Thorac. Cardiovasc. Surg. 2005, 129 (1) 87-93
2. Smith, R. A.; Cokkinides, V.; Brooks, D.; Saslow, D.; Brawley, O. W. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J. Clin. 2010, 60 (2) 99-119
3. Kaneko, M.; Eguchi, K.; Ohmatsu, H.; Kakinuma, R.; Naruke, T.; Suemasu, K. Moriyama N.Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography Radiology 1996, 201 (3) 798-802
4. Welch, H. G.; Woloshin, S.; Schwartz, L. M.; Gordis, L.; Gøtzsche, P. C.; Harris, R.; Kramer, B. S.; Ransohoff, D. F. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study Arch. Intern. Med. 2007, 167 (21) 2289-95
5. Wilson, D. O.; Weissfeld, J. L.; Fuhrman, C. R.; Fisher, S. N.; Balogh, P.; Landreneau, R. J.; Luketich, J. D.; Siegfried, J. M. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan Am. J. Respir. Crit. Care Med. 2008, 178 (9) 956-61
6. Stamey, T. A.; Yang, N.; Hay, A. R.; McNeal, J. E.; Freiha, F. S.; Redwine, E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N. Engl. J. Med. 1987, 317 (15) 909-16
7. Fujino, N.; Haga, Y.; Sakamoto, K.; Egami, H.; Kimura, M. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen Jpn. J. Clin. Oncol. 1986, 16 (4) 335-46
8. Gadducci, A.; Cosio, S.; Carpi, A.; Nicolini, A.; Genazzani, A. R. Serum tumor markers in the management of ovarian, endometrial and cervical cancer Biomed. Pharmacother. 2004, 58 (1) 24-38
9. Tan, E.; Gouvas, N.; Nicholls, R. J.; Ziprin, P.; Xynos, E.; Tekkis, P. P. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer Surg. Oncol. 2009, 18 (1) 15-24
10. Anderson, N. L.; Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics. 2002, 1 (11) 845-67
11. Zhang, H.; Yan, W.; Aebersold, R. Chemical probes and tandem mass spectrometry: a strategy for the quantitative analysis of proteomes and subproteomes Curr. Opin. Chem. Biol. 2004, 8 (1) 66-75
12. Apweiler, R.; Hermjakob, H.; Sharon, N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database Biochim. Biophys. Acta 1999, 1473 (1) 4-8
13. Tong, L.; Baskaran, G.; Jones, M. B.; Rhee, J. K.; Yarema, K. J. Glycosylation changes as markers for the diagnosis and treatment of human disease Biotechnol. Genet. Eng. Rev. 2003, 20, 199-244
14. Zhang, H.; Li, X. J.; Martin, D. B.; Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry Nat. Biotechnol. 2003, 21 (6) 660-6
15. Tian, Y.; Zhou, Y.; Elliott, S.; Aebersold, R.; Zhang, H. Solid-phase extraction of N-linked glycopeptides Nat. Protoc. 2007, 2 (2) 334-9
16. Sun, B.; Ranish, J. A.; Utleg, A. G.; White, J. T.; Yan, X.; Lin, B.; Hood, L. Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics Mol. Cell. Proteomics. 2007, 6 (1) 141-9
17. Kaji, H.; Saito, H.; Yamauchi, Y.; Shinkawa, T.; Taoka, M.; Hirabayashi, J.; Kasai, K.; Takahashi, N.; Isobe, T. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins Nat. Biotechnol. 2003, 21 (6) 667-72
18. Ueda, K.; Katagiri, T.; Shimada, T.; Irie, S.; Sato, T. A.; Nakamura, Y.; Daigo, Y. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer J. Proteome Res. 2007, 6 (9) 3475-83
19. Hongsachart, P.; Huang-Liu, R.; Sinchaikul, S.; Pan, F. M.; Phutrakul, S.; Chuang, Y. M.; Yu, C. J.; Chen, S. T. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma Electrophoresis 2009, 30 (7) 1206-20
20. Heo, S. H.; Lee, S. J.; Ryoo, H. M.; Park, J. Y.; Cho, J. Y. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS Proteomics 2007, 7 (23) 4292-302
21. Old, W. M.; Meyer-Arendt, K.; Aveline-Wolf, L.; Pierce, K. G.; Mendoza, A.; Sevinsky, J. R.; Resing, K. A.; Ahn, N. G. Comparison of label-free methods for quantifying human proteins by shotgun proteomics Mol. Cell. Proteomics 2005, 4 (10) 1487-502
22. Wong, J. W.; Cagney, G. An overview of label-free quantitation methods in proteomics by mass spectrometry Methods Mol. Biol. 2010, 604, 273-83
23. Thermo Xcalibur raw file to mzXML converter, ReAdW version 4.2.0 was downloaded from http://tools.proteomecenter.org/wiki/index.php?title=Software: ReAdW.
24. Cleveland, W. S. Robust locally weighted regression and smoothing scatterplots J. Amer. Stat. Assoc. 1979, 74 (368) 829-36
25. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing J. R. Stat. Soc. 1995, 57, 289-300
26. Lindner, H.; Helliger, W. Age-dependent deamidation of asparagine residues in proteins Exp. Gerontol. 2001, 36 (9) 1551-63
27. Harazono, A.; Kawasaki, N.; Kawanishi, T.; Hayakawa, T. Site-specific glycosylation analysis of human apolipoprotein B100 using LC/ESI MS/MS Glycobiology 2005, 15 (5) 447-62
28. Chen, B.; Liu, S.; Xu, W.; Wang, X.; Zhao, W.; Wu, J. IGF-I and IGFBP-3 and the risk of lung cancer: a meta-analysis based on nested case-control studies J. Exp. Clin. Cancer Res. 2009, 28, 89-94
29. The networks and functional analyses were generated through the use of Ingenuity Pathways Analysis (Ingenuity Systems, www.ingenuity.com).
30. Grivennikov, S. I.; Greten, F. R.; Karin, M. Immunity, inflammation, and cancer Cell 2010, 140 (6) 883-99
31. Liu, T.; Qian, W. J.; Gritsenko, M. A.; Camp, D. G., 2nd; Monroe, M. E.; Moore, R. J.; Smith, R. D. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry J. Proteome Res. 2005, 4 (6) 2070-80
32. Okano, T.; Kondo, T.; Kakisaka, T.; Fujii, K.; Yamada, M.; Kato, H.; Nishimura, T.; Gemma, A.; Kudoh, S.; Hirohashi, S. Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis Proteomics 2006, 6 (13) 3938-48
33. Welch, H. G.; Woloshin, S.; Schwartz, L. M.; Gordis, L.; Gøtzsche, P. C.; Harris, R.; Kramer, B. S.; Ransohoff, D. F. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study Arch. Intern. Med. 2007, 167 (21) 2289-95
34. Wilson, D. O.; Weissfeld, J. L.; Fuhrman, C. R.; Fisher, S. N.; Balogh, P.; Landreneau, R. J.; Luketich, J. D.; Siegfried, J. M. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan Am. J. Respir. Crit. Care Med. 2008, 178 (9) 956-61
35. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5 (4) 573-88
36. Kuzyk, M. A.; Smith, D.; Yang, J.; Cross, T. J.; Jackson, A. M.; Hardie, D. B.; Anderson, N. L.; Borchers, C. H. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol. Cell. Proteomics 2009, 8 (8) 1860-77
37. Abbatiello, S. E.; Pan, Y. X.; Zhou, M.; Wayne, A. S.; Veenstra, T. D.; Hunger, S. P.; Kilberg, M. S.; Eyler, J. R.; Richards, N. G.; Conrads, T. P. Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients J. Proteomics 2008, 71 (1) 61-70